1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients
Status:
Completed
Trial end date:
2020-10-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if there are any differences in patient reported
neurotoxicity between patients who receive Levetiracetam tablets for one week after surgery
to remove a brain tumor versus those who receive Levetiracetam tablets for six weeks after
surgery. Specifically, we will see if one group has less side effects than the other, and
whether or not one group has more seizures than the other.